Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.

Sarbach C, Stevens P, Whiting J, Puget P, Humbert M, Cohen-Kaminsky S, Postaire E

Open source

DOI
10.1016/j.pharma.2013.05.002
Published
2013 Jul
Container
Annales pharmaceutiques francaises
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pharma.2013.05.002,
  title = {Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.},
  author = {Sarbach C and Stevens P and Whiting J and Puget P and Humbert M and Cohen-Kaminsky S and Postaire E},
  year = {2013},
  journal = {Annales pharmaceutiques francaises},
  doi = {10.1016/j.pharma.2013.05.002},
  url = {https://doi.org/10.1016/j.pharma.2013.05.002}
}

RIS

TY  - JOUR
TI  - Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
AU  - Sarbach C
AU  - Stevens P
AU  - Whiting J
AU  - Puget P
AU  - Humbert M
AU  - Cohen-Kaminsky S
AU  - Postaire E
PY  - 2013
JO  - Annales pharmaceutiques francaises
DO  - 10.1016/j.pharma.2013.05.002
UR  - https://doi.org/10.1016/j.pharma.2013.05.002
ER  - 

APA

C, S., P, S., J, W., P, P., M, H., S, C., & E, P. (2013). Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.. Annales pharmaceutiques francaises. https://doi.org/10.1016/j.pharma.2013.05.002

Source records